Lipid phosphate phosphatase (LPP3) and vascular development.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Biochimica et Biophysica Acta

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbalip.2012.07.012PMID 22835522PMCID PMC3683602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mice With Targeted Inactivation of Ppap2b in Endothelial and Hematopoietic Cells Display Enhanced Vascular Inflammation and Permeability

  2014cited by this paper
• Lipid Phosphate Phosphatases: Recent Progress and Assay Methods

  2013cited by this paper
• Lysophospholipid Receptors: Signaling and Biochemistry

  2013cited by this paper
• Treatment options for the management of hypertriglyceridemia: strategies based on the best-available evidence.

  2012cited by this paper
• Abstract 17554: Mice with Endothelial-Targeted Inactivation of Ppap2b (Lipid Phosphate Phosphatase 3) Display Enhanced Vascular Inflammation

  2011cited by this paper
• Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

  2011cited by this paper
• Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M

  2011cited by this paper
• Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions

  2011cited by this paper
• Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.

  2011cited by this paper
• Autotaxin Regulates Vascular Development via Multiple Lysophosphatidic Acid (LPA) Receptors in Zebrafish*

  2011cited by this paper
• Release of sphingosine‐1‐phosphate from human platelets is dependent on thromboxane formation

  2011cited by this paper
• Lysophosphatidic acid effects on atherosclerosis and thrombosis.

  2011cited by this paper
• Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury.

  2010cited by this paper
• Tumor and Stem Cell Biology Cancer Research S 1 P 2 , the G Protein – Coupled Receptor for Sphingosine-1-Phosphate , Negatively Regulates Tumor Angiogenesis and Tumor Growth In vivo in Mice

  2010cited by this paper
• LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis.

  2010cited by this paper
• Roles of sphingosine-1-phosphate signaling in angiogenesis.

  2010cited by this paper
• ATX expression and LPA signalling are vital for the development of the nervous system.

  2010cited by this paper
• Lipid Phosphate Phosphatase 3 Stabilization of β-Catenin Induces Endothelial Cell Migration and Formation of Branching Point Structures

  2010cited by this paper
• Extracellular and intracellular actions of sphingosine-1-phosphate.

  2010cited by this paper
• Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.

  2010cited by this paper
• Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo.

  2009cited by this paper
• Autotaxin/Lysophospholipase D-mediated Lysophosphatidic Acid Signaling Is Required to Form Distinctive Large Lysosomes in the Visceral Endoderm Cells of the Mouse Yolk Sac*

  2009cited by this paper
• Sp-1 and c-Myc Mediate Lysophosphatidic Acid–Induced Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Cells via a Hypoxia-Inducible Factor-1–Independent Mechanism

  2009cited by this paper
• Tyrosine sulphation of sphingosine 1-phosphate 1 (S1P1) is required for S1P-mediated cell migration in primary cultures of human umbilical vein endothelial cells.

  2009cited by this paper
• Phosphatidate degradation: phosphatidate phosphatases (lipins) and lipid phosphate phosphatases.

  2009cited by this paper
• Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.

  2009cited by this paper
• Generation of a reporter-null allele of Ppap2b/Lpp3and its expression during embryogenesis.

  2009cited by this paper
• The plasma concentration of Lpa-I:A-II particles as a predictor of the inflammatory response in patients with ST-elevation myocardial infarction.

  2009cited by this paper
• Lipid phosphate phosphatases and signaling The work was supported by the Canadian Institutes of Health Research. Published, JLR Papers in Press, December 9, 2008.

  2009cited by this paper
• Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and Thrombosis*

  2009cited by this paper
• Inducible Capillary Formation in Lymphatic Endothelial Cells by Blocking Lipid Phosphate Phosphatase-3 Activity

  2009cited by this paper
• G protein–coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth

  2008cited by this paper
• LPA modulates monocyte migration directly and via LPA-stimulated endothelial cells.

  2008cited by this paper
• Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.

  2008cited by this paper
• Sphingosine 1-phosphate attenuates H2O2-induced apoptosis in endothelial cells.

  2008cited by this paper
• Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor.

  2008cited by this paper
• The vascular S1P gradient-cellular sources and biological significance.

  2008cited by this paper
• Lipid phosphate phosphatases form homo- and hetero-oligomers: catalytic competency, subcellular distribution and function.

  2008cited by this paper
• Lysophospholipid interactions with protein targets.

  2008cited by this paper
• Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory

  2007cited by this paper
• Deafness and Stria Vascularis Defects in S1P2 Receptor-null Mice*

  2007cited by this paper
• Vascular effects of sphingolipids

  2007cited by this paper
• Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal

  2007cited by this paper
• The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor.

  2007cited by this paper
• Splicing in disease: disruption of the splicing code and the decoding machinery

  2007cited by this paper
• Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo

  2006cited by this paper
• Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development

  2006cited by this paper
• Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid*

  2006cited by this paper
• Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor.

  2006cited by this paper
• Lipid phosphate phosphatases 1 and 3 are localized in distinct lipid rafts.

  2006cited by this paper
• Murine lipid phosphate phosphohydrolase-3 acts as a cell-associated integrin ligand.

  2005cited by this paper
• Lipid phosphate phosphatases and lipid phosphate signalling.

  2005cited by this paper
• Anti-lipid phosphate phosphohydrolase-3 (LPP3) antibody inhibits bFGF- and VEGF-induced capillary morphogenesis of endothelial cells

  2005cited by this paper
• Lysophospholipids enhance matrix metalloproteinase-2 expression in human endothelial cells.

  2005cited by this paper
• Integral membrane lipid phosphatases/phosphotransferases: common structure and diverse functions.

  2005influential reference
• From SNPs to function: the effect of sequence variation on gene expression. Focus on "a survey of genetic and epigenetic variation affecting human gene expression".

  2004cited by this paper
• G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival

  2004cited by this paper
• Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury.

  2004cited by this paper
• A survey of genetic and epigenetic variation affecting human gene expression.

  2004cited by this paper
• The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic Angiogenesis*

  2004cited by this paper
• Lipid phosphate phosphatases dimerise, but this interaction is not required for in vivo activity

  2004cited by this paper
• Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.

  2004cited by this paper
• Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis.

  2004cited by this paper
• Phosphorylation and Action of the Immunomodulator FTY720 Inhibits Vascular Endothelial Cell Growth Factor-induced Vascular Permeability*

  2003cited by this paper
• Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family*

  2003cited by this paper
• Inhibitory and Stimulatory Regulation of Rac and Cell Motility by the G12/13-Rho and Gi Pathways Integrated Downstream of a Single G Protein-Coupled Sphingosine-1-Phosphate Receptor Isoform

  2003cited by this paper
• The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.

  2003cited by this paper
• The emerging role of lysophosphatidic acid in cancer

  2003cited by this paper
• G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation.

  2003influential reference
• The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning

  2003influential reference
• Differential localization of lipid phosphate phosphatases 1 and 3 to cell surface subdomains in polarized MDCK cells

  2003cited by this paper
• Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene.

  2003cited by this paper
• Regulation of cell–cell interactions by phosphatidic acid phosphatase 2b/VCIP

  2003cited by this paper
• Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production

  2002cited by this paper
• Cognitive Outcomes Following Cardiopulmonary Bypass

  2002cited by this paper
• Lipid phosphate phosphatases regulate signal transduction through glycerolipids and sphingolipids.

  2002cited by this paper
• Roles for lipid phosphate phosphatases in regulation of cellular signaling.

  2002cited by this paper
• Plasma lysophosphatidic acid concentration and ovarian cancer.

  2002cited by this paper
• Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins.

  2001cited by this paper
• Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3*

  2001cited by this paper
• p120 catenin affects cell motility via modulation of activity of Rho-family GTPases: a link between cell-cell contact formation and regulation of cell locomotion.

  2001cited by this paper
• Sphingosine 1-Phosphate-induced Endothelial Cell Migration Requires the Expression of EDG-1 and EDG-3 Receptors and Rho-dependent Activation of αvβ3- and β1-containing Integrins*

  2001cited by this paper
• Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.

  2000cited by this paper
• Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.

  2000cited by this paper
• Functions of a new family of sphingosine-1-phosphate receptors.

  2000cited by this paper
• Lysophospholipid‐Induced Cell Migration

  2000cited by this paper
• Inhibitory Regulation of Rac Activation, Membrane Ruffling, and Cell Migration by the G Protein-Coupled Sphingosine-1-Phosphate Receptor EDG5 but Not EDG1 or EDG3

  2000cited by this paper
• Cell surface activities of the human type 2b phosphatidic acid phosphatase.

  2000cited by this paper
• Lysophosphatidic acid and sphingosine 1-phosphate stimulate endothelial cell wound healing.

  2000cited by this paper
• Brachyury is a target gene of the Wnt/beta-catenin signaling pathway.

  2000cited by this paper
• Bioactive lysophospholipids and their G protein-coupled receptors.

  1999cited by this paper
• Induction of Endothelial Cell Chemotaxis by Sphingosine 1-Phosphate and Stabilization of Endothelial Monolayer Barrier Function by Lysophosphatidic Acid, Potential Mediators of Hematopoietic Angiogenesis

  1999cited by this paper
• Molecular Cloning and Characterization of a Novel Human G-protein-coupled Receptor, EDG7, for Lysophosphatidic Acid*

  1999cited by this paper
• Differential Coupling of the Sphingosine 1-Phosphate Receptors Edg-1, Edg-3, and H218/Edg-5 to the Gi, Gq, and G12 Families of Heterotrimeric G Proteins*

  1999cited by this paper
• Activation of phospholipase C‐Ca2+ system by sphingosine 1‐phosphate in CHO cells transfected with Edg‐3, a putative lipid receptor

  1999cited by this paper
• Human Type 2 Phosphatidic Acid Phosphohydrolases

  1998cited by this paper
• EDG1 Is a Functional Sphingosine-1-phosphate Receptor That Is Linked via a Gi/o to Multiple Signaling Pathways, Including Phospholipase C Activation, Ca2+Mobilization, Ras-Mitogen-activated Protein Kinase Activation, and Adenylate Cyclase Inhibition*

  1998cited by this paper
• Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid*

  1998cited by this paper
• Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.

  1998cited by this paper
• Signaling mechanisms and molecular characteristics of G protein‐coupled receptors for lysophosphatidic acid and sphingosine 1‐phosphate

  1998cited by this paper

• Structural basis for the catalytic mechanism of human lipid phosphate phosphatases.

  2026cites this paper
• Hedgehog and Drosophila germ cell migration

  2025cites this paper
• Disruption of the peripheral biological clock may play a role in sleep deprivation-induced dysregulation of lipid metabolism in both the daytime and nighttime phases.

  2024cites this paper
• Wun2-mediated integrin recycling promotes apoptotic cell clearance in Drosophila melanogaster.

  2022cites this paper
• PLPP2: Potential therapeutic target of breast cancer in PLPP family.

  2022cites this paper
• Lipid phosphate phosphatase 3 maintains NO‐mediated flow‐mediated dilatation in human adipose resistance arterioles

  2022cites this paper
• A role for bronchial epithelial autotaxin in ventilator-induced lung injury

  2021cites this paper
• Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target

  2021cites this paper
• Non-Epithelial Stromal Cells in Thymus Development and Function

  2021influential citation
• Nlrp3 Inflammasome Signaling Regulates the Homing and Engraftment of Hematopoietic Stem Cells (HSPCs) by Enhancing Incorporation of CXCR4 Receptor into Membrane Lipid Rafts

  2020cites this paper
• Cross-Species Insights Into Genomic Adaptations to Hypoxia

  2020cites this paper
• Associating Type 2 Diabetes Risk Factor Genes and FDG-PET Brain Metabolism in Normal Aging and Alzheimer’s Disease

  2020cites this paper
• Lipid Phosphate Phosphatases and Cancer

  2020cites this paper
• Regulation of PLPP3 gene expression by NF-κB family transcription factors

  2019cites this paper
• Increasing the low lipid phosphate phosphatase 1 activity in breast cancer cells decreases transcription by AP-1 and expressions of matrix metalloproteinases and cyclin D1/D3

  2019cites this paper
• Lipid phosphate phosphatase 3 in vascular pathophysiology.

  2018cites this paper
• Study of the association of 17 lipid-related gene polymorphisms with coronary heart disease

  2018cites this paper
• Autotaxin in Pathophysiology and Pulmonary Fibrosis

  2018cites this paper
• Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis

  2018cites this paper
• Role of lysophosphatidic acid and its receptors in the kidney.

  2017cites this paper
• Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE−/− mice

  2017cites this paper
• Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure

  2017cites this paper
• Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome[S]

  2017cites this paper
• Lipid phosphate phosphatases (Lpps) and its role in mitochondrial function

  2016cites this paper
• Role of lipid phosphate phosphatase 3 in human aortic endothelial cell function.

  2016cites this paper
• Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis.

  2016cites this paper
• Vascular sphingolipids in physiological and pathological adaptation.

  2016cites this paper
• Effects of Cigarette Smoke, Cessation, and Switching to Two Heat-Not-Burn Tobacco Products on Lung Lipid Metabolism in C57BL/6 and Apoe−/− Mice—An Integrative Systems Toxicology Analysis

  2015cites this paper
• Emerging Strategies to Enhance Homing and Engraftment of Hematopoietic Stem Cells

  2015influential citation
• Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis

  2015cites this paper
• Mechanosensitive PPAP2B Regulates Endothelial Responses to Atherorelevant Hemodynamic Forces.

  2015cites this paper
• Lipid-Induced Epigenomic Changes in Human Macrophages Identify a Coronary Artery Disease-Associated Variant that Regulates PPAP2B Expression through Altered C/EBP-Beta Binding

  2015cites this paper
• Translating GWAS Into the Flow-Regulated Modulation of Lipid Mediator Signaling.

  2015cites this paper
• Growth Hormone-Regulated mRNAs and miRNAs in Chicken Hepatocytes

  2014cites this paper
• Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.

  2014cites this paper
• Pericytes prevent regression of endothelial cell tubes by accelerating metabolism of lysophosphatidic acid.

  2014cites this paper
• Autotaxin: structure-function and signaling

  2014cites this paper
• Crystal structure of lipid phosphatase Escherichia coli phosphatidylglycerophosphate phosphatase B

  2014cites this paper
• Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice: role of blood cell-associated lysophospholipase D activity of autotaxin.

  2014cites this paper
• Association between Phosphatase Related Gene Variants and Coronary Artery Disease: Case-Control Study and Meta-Analysis

  2014cites this paper
• Lipid Phosphate Phosphatase 3 Negatively Regulates Smooth Muscle Cell Phenotypic Modulation to Limit Intimal Hyperplasia

  2013influential citation
• Compartmentalizing the embryo

  2012cites this paper